Robert F. Vizza Clinical Accelerator Initiative
The Clinical Accelerator Initiative (CAI) advances the mission of the Lustgarten Foundation by accelerating the translation of research discoveries into the clinic. CAI studies are highly collaborative, science-driven and typically small in order to support deep translational analyses and as many learnings as possible.
Last confirmed Aug 24, 2026 · Funder website
Robert F. Vizza Clinical Accelerator Initiative: Eligibility, Deadline, and Award Questions
Who is eligible for Robert F. Vizza Clinical Accelerator Initiative?
Robert F. Vizza Clinical Accelerator Initiative eligibility includes eligible applicants named in the notice. Geographic eligibility is MA, CA, NY, PA, NC, CT, MD and MI; applicants should confirm the source notice before applying.
What is the deadline for Robert F. Vizza Clinical Accelerator Initiative?
Robert F. Vizza Clinical Accelerator Initiative has a listed deadline of November 2, 2026. Grant deadlines can change, so verify the current date with MARC LUSTGARTEN PANCREATIC CANCER before submitting.
How much funding is available for Robert F. Vizza Clinical Accelerator Initiative?
Robert F. Vizza Clinical Accelerator Initiative lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.
Who funds Robert F. Vizza Clinical Accelerator Initiative?
Robert F. Vizza Clinical Accelerator Initiative is funded by MARC LUSTGARTEN PANCREATIC CANCER. GrantSonar tracks the notice with source ID 311611837:robert-f-vizza-clinical-accelerator-initiative from funder_site.
Eligibility facets
Not listed in source metadata.
MA, CA, NY, PA, NC, CT, MD, MI
Not disclosed in source metadata.
Funder website · 311611837:robert-f-vizza-clinical-accelerator-initiative
Check whether this grant fits your organization
GrantSonar compares the notice against your mission, geography, eligibility, and programs before you spend time writing.